Table 1. Clinical and pathological characteristics of 45 patients harboring thyroid nodules confirmed as papillary thyroid carcinoma and preoperatively submitted to molecular analysis of pTERT and BRAFV600E mutations.
| Variables | n | % | |
|---|---|---|---|
| Gender | |||
| Male | 6 | 13.3 | |
| Female | 39 | 86.7 | |
| Age, mean (sd) | 48.5 (14.33) | ||
| ≤ 55 | 23 | 51.1 | |
| > 55 | 22 | 48.9 | |
| Tumor size | |||
| ≤ 1 cm | 13 | 29.5 | |
| > 1 cm | 31 | 70.5 | |
| Multicentricity | |||
| Absent | 34 | 75.6 | |
| Present | 11 | 24.4 | |
| Extrathyroid extension | |||
| Absent | 41 | 91.1 | |
| Present | 4 | 8.9 | |
| Lymphnode metastases | |||
| Absent | 38 | 84.4 | |
| Present | 7 | 15.6 | |
| AJCC stage | |||
| I+II | 33 | 75.0 | |
| III+IV | 11 | 25.0 | |
| Capsular invasion | |||
| Absent | 37 | 82.2 | |
| Present | 8 | 17.8 | |
| BRAF status | |||
| Wild Type | 15 | 33.3 | |
| Mutated | 30 | 66.7 | |
| TERT status | |||
| Wild Type | 41 | 91.1 | |
| Mutated | 4 | 8.9 | |